Get started
Author

John A. Laurie

Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
1990 · Charles G. Moertel, Thomas R. Fleming, et al. · New England Journal of Medicine · 2,256
PDF
Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.
1989 · M A Poon, M J O'Connell, et al. · Journal of Clinical Oncology · 887
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.
1989 · J A Laurie, C G Moertel, et al. · Journal of Clinical Oncology · 700
Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.
1998 · M J O'Connell, J A Laurie, et al. · Journal of Clinical Oncology · 417
Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group.
1994 · C L Loprinzi, J A Laurie, et al. · Journal of Clinical Oncology · 384
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.
1995 · C G Moertel, T R Fleming, et al. · Journal of Clinical Oncology · 369
Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity
1996 · Maureen S. Williams, Mary Burk, et al. · International Journal of Radiation Oncology*Biology*Physics · 238
Prognostic Impact of Microsatellite Instability and DNA Ploidy in Human Colon Carcinoma Patients
2006 · Frank A. Sinicrope, Rafaela L. Rego, et al. · Gastroenterology · 230
PDF
Thoracic Radiation Therapy Alone Compared with Combined Chemoradiotherapy for Locally Unresectable Non-Small Cell Lung Cancer
1991 · Roscoe F. Morton, James R. Jett, et al. · Annals of Internal Medicine · 190
Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy.
1993 · C G Moertel, T R Fleming, et al. · Journal of Clinical Oncology · 124
A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.
1985 · T R Buroker, C G Moertel, et al. · Journal of Clinical Oncology · 118
Cyclophosphamide-Cisplatin Versus Cyclophosphamide-Carboplatin in Stage III-IV Ovarian Carcinoma: A Comparison of Equally Myelosuppressive Regimens
1989 · J. H. Edmonson, G. M. McCormack, et al. · JNCI Journal of the National Cancer Institute · 59
Thymidylate Synthase Expression in Colon Carcinomas with Microsatellite Instability
2006 · Frank A. Sinicrope, Rafaela L. Rego, et al. · Clinical Cancer Research · 43
PDF
An Evaluation of Postoperative Follow-Up Tests in Colon Cancer Patients Treated for Cure
2009 · Prema Peethambaram, Matthias Weiss, et al. · Oncology · 34
Postchemotherapy Nausea and Vomiting in Cancer Patients Receiving outpatient Chemotherapy
1991 · Marc W. Haut, Bill E. Beckwith, et al. · Journal of Psychosocial Oncology · 31
Chemotherapy for hormonally refractory advanced prostate carcinoma. A Comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil
1992 · John A. Laurie, Richard G. Hahn, et al. · Cancer · 26
Pilot study of accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage III non-small cell lung carcinoma
1993 · Jeffrey S. Brindle, Edward G. Shaw, et al. · Cancer · 18
Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
1983 · H Windschitl, M Scott, et al. · PubMed · 17
Randomized clinical trial of doxorubicin alone or combined with mitolactol in women with advanced breast cancer and prior chemotherapy exposure
1985 · James N. Ingle, Stephanie J. Green, et al. · American Journal of Clinical Oncology · 14
A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancer.
1985 · J E Krook, J R Jett, et al. · Journal of Clinical Oncology · 13
A new graphic for quality adjusted life years (Q-TWiST) survival analysis: The Q-TWiST plot
2002 · Jeff A. Sloan, Daniel J. Sargent, et al. · Quality of Life Research · 12
A clinical trial of biochemical modulation of 5-fluorouracil with N-phosphonoacetyl-L-aspartate and thymidine in advanced gastric and anaplastic colorectal cancer
1990 · Harold E. Windschitl, Michael J. O'Connell, et al. · Cancer · 8
PDF
Alternating Chemotherapy With or Without VP-16 in Extensive-Stage Small-Cell Lung Cancer
1989 · Lloyd K. Everson, James R. Jett, et al. · American Journal of Clinical Oncology · 8
Phase II study of bisantrene administered by continuous 72‐hour infusion for advanced pancreatic adenocarcinoma
1988 · Robert F. Marschke, Larry K. Kvols, et al. · Medical and Pediatric Oncology · 3
Phase II evaluation of menogaril in patients with advanced cervical carcinoma
1991 · Harry J. Long, Harry S. Wieand, et al. · Investigational New Drugs · 1
Works count: 30
Citation count: 6,201
H-index: 17
I10-index: 21
Year
Topic
Type